{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:35Z","timestamp":1791272135890,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010651","name":"Jacob and Hilda Blaustein Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010651","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Krieger Fund"},{"name":"Open Society Institute \u2013 Baltimore"},{"name":"Leonard and Helen R. Stulman Foundation"},{"DOI":"10.13039\/100005317","name":"Abell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F31DA047021"],"award-info":[{"award-number":["F31DA047021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jsat.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:48:55Z","timestamp":1557409735000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap"],"prefix":"10.1016","volume":"103","author":[{"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Buresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1078345816634079","article-title":"Screaming behind a door: The experiences of individuals incarcerated without medication-assisted treatment","volume":"22","author":"Aronowitz","year":"2016","journal-title":"Journal of Correctional Health Care"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11606-006-0050-y","article-title":"Patient satisfaction with primary care office-based buprenorphine\/naloxone treatment","volume":"22","author":"Barry","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2019.05.002_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: Perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison \u2014 A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1057\/jphp.2014.54","article-title":"State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness","volume":"36","author":"Bramson","year":"2015","journal-title":"Journal of Public Health Policy"},{"key":"10.1016\/j.jsat.2019.05.002_bb0035","author":"Bronson"},{"issue":"8","key":"10.1016\/j.jsat.2019.05.002_bb0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The role of behavioral interventions in buprenorphine maintenance treatment: A review","volume":"174","author":"Carroll","year":"2017","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2019.05.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2019.05.002_bb0055","doi-asserted-by":"crossref","unstructured":"Daniels, A. M., Salisbury-Afshar, E., Hoffberg, A., Agus, D., and Fingerhood, M. I. (2014). A novel community-based buprenorphine program: Client description and initial outcomes. Journal of Addiction Medicine, 8(1), 40\u201346. From the Autism Speaks (AMD), New York; and Johns Hopkins Bloomberg School of Public Health (ES-A, DA), Behavioral Health Leadership Institute (AH, DA), and Johns Hopkins University, Johns Hopkins Bayview Medical Center (MIF), Baltimore, MD. doi:https:\/\/doi.org\/10.1097\/ADM.0000000000000004 [doi].","DOI":"10.1097\/ADM.0000000000000004"},{"key":"10.1016\/j.jsat.2019.05.002_bb0060","series-title":"Co-occurring addictive and psychiatric disorders","first-page":"349","article-title":"Somatic problems and dual disorder patients","author":"De Hert","year":"2015"},{"issue":"7","key":"10.1016\/j.jsat.2019.05.002_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1176\/appi.ps.53.7.861","article-title":"Medical morbidity, mental illness, and substance use disorders","volume":"53","author":"Dickey","year":"2002","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2019.05.002_bb0070","first-page":"1","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"22","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0080","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10578-011-0270-1","article-title":"The mental and physical health of homeless youth: A literature review","volume":"43","author":"Edidin","year":"2012","journal-title":"Child Psychiatry & Human Development"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12913-016-1692-z","article-title":"Medical encounters for opioid-related intoxications in southern Nevada: Sociodemographic and clinical correlates","volume":"16","author":"Feng","year":"2016","journal-title":"BMC Health Services Research"},{"issue":"9","key":"10.1016\/j.jsat.2019.05.002_bb0090","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamainternmed.2018.3504","article-title":"Implementing opioid agonist treatment in correctional facilities","volume":"178","author":"Fiscella","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2019.05.002_bb0100","doi-asserted-by":"crossref","unstructured":"Friedmann, P. D., Hoskinson Jr, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., Flynn, P. M., et al. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33(1), 9\u201318. Taylor & Francis.","DOI":"10.1080\/08897077.2011.611460"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2019.05.002_bb0105","first-page":"S135","article-title":"Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration","volume":"117 Suppl 1","author":"Galea","year":"2002","journal-title":"Public Health Reports"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2013.05.022","article-title":"Is opioid substitution treatment beneficial if injecting behaviour continues?","volume":"133","author":"Gjersing","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2019.05.002_bb0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/bsl.1015","article-title":"Medication-assisted treatment research with criminal justice populations: Challenges of implementation","volume":"29","author":"Gordon","year":"2011","journal-title":"Behavioral Sciences & the Law"},{"issue":"4","key":"10.1016\/j.jsat.2019.05.002_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0376-8716(96)01273-2","article-title":"Patient retention in mobile and fixed-site methadone maintenance treatment","volume":"42","author":"Greenfield","year":"1996","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2019.05.002_bb0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2019.05.002_bb0135","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.mayocp.2013.12.008","article-title":"Epidemiology of emergency department visits for opioid overdose: A population-based study","volume":"89","author":"Hasegawa","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.jsat.2019.05.002_bb0140","article-title":"Drug overdose deaths in the United States, 1999-2015","volume":"273","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"8","key":"10.1016\/j.jsat.2019.05.002_bb0145","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"Journal Information"},{"key":"10.1016\/j.jsat.2019.05.002_bb0150","author":"Kaeble"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0740-5472(03)00026-6","article-title":"Slowing the revolving door: Stabilization programs reduce homeless persons' substance use after detoxification","volume":"24","author":"Kertesz","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.05.002_bb0160","series-title":"Lowinson & Ruiz's substance abuse: A comprehensive textbook","first-page":"881","article-title":"Incarcerated populations","author":"Kinlock","year":"2011"},{"key":"10.1016\/j.jsat.2019.05.002_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2019.05.002_bb0170","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Affairs"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care","volume":"24","author":"Lee","year":"2009","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2019.05.002_bb0180","series-title":"How America's prisons are fueling the opioid epidemic","author":"Lopez","year":"2018"},{"key":"10.1016\/j.jsat.2019.05.002_bb0185","author":"Maryland Department of Health and Mental Hygiene"},{"issue":"5","key":"10.1016\/j.jsat.2019.05.002_bb0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v25n03_11","article-title":"Prescribing naloxone to actively injecting heroin users","volume":"25","author":"Maxwell","year":"2006","journal-title":"Journal of Addictive Diseases"},{"issue":"9","key":"10.1016\/j.jsat.2019.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2019.05.002_bb0205","author":"National Alliance for Model State Drug Laws"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2019.05.002_bb0215","author":"Oros"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ADM.0b013e318287cfc9","article-title":"Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry","volume":"7","author":"Peles","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/10826084.2014.957769","article-title":"Psychological predictors of retention in a low-threshold methadone maintenance treatment for opioid addicts: A 1-year follow-up study","volume":"50","author":"Perreault","year":"2015","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2019.05.002_bb0230","first-page":"e1","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000-2015","author":"Ranapurwala","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: Patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-1-7","article-title":"Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users?","volume":"1","author":"Rogers","year":"2004","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.jsat.2019.05.002_bb0245","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13776","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"16","author":"Rudd","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1016\/j.jsat.2019.05.002_bb0250","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction"},{"issue":"25","key":"10.1016\/j.jsat.2019.05.002_bb0255","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1610047","article-title":"Interim buprenorphine vs. waiting list for opioid dependence","volume":"375","author":"Sigmon","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1377\/hlthaff.2011.1392","article-title":"Mobile clinic in Massachusetts associated with cost savings from lowering blood pressure and emergency department use","volume":"32","author":"Song","year":"2013","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2019.05.002_bb0265","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"Supplement_4","key":"10.1016\/j.jsat.2019.05.002_bb0270","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1086\/508183","article-title":"Initial strategies for integrating buprenorphine into HIV care settings in the United States","volume":"43","author":"Sullivan","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"9","key":"10.1016\/j.jsat.2019.05.002_bb0280","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1377\/hlthaff.2013.0228","article-title":"Medicaid expansion: Chronically homeless adults will need targeted enrollment and access to a broad range of services","volume":"32","author":"Tsai","year":"2013","journal-title":"Health Affairs"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2019.05.002_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2019.05.002_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.jsat.2019.05.002_bb0290","series-title":"Federal ban on methadone vans seen as barrier to treatment","author":"Vestal","year":"2018"},{"issue":"2\u20133","key":"10.1016\/j.jsat.2019.05.002_bb0295","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/10550887.2015.1059217","article-title":"Addiction treatment within U.S. correctional facilities: Bridging the gap between current practice and evidence-based care","volume":"34","author":"Wakeman","year":"2015","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2019.05.002_bb0300","author":"Walsh"},{"issue":"3","key":"10.1016\/j.jsat.2019.05.002_bb0305","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.jsat.2019.05.002_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"Journal of Addictive Diseases"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721830446X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721830446X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:49:16Z","timestamp":1760039356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054721830446X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":62,"alternative-id":["S074054721830446X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.05.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}